Sciwind Biosciences APAC CO Pty. Ltd.

For profit

Also known as: Hangzhou Sciwind Biosciences Co., Ltd. | Sciwind Biosciences APAC CO Pty. Ltd. | Sciwind Biosciences USA Co., Ltd | Sciwind Biosciences USA Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 29, 2020

Last known activity

Nov 18, 2025

Timeline

2010s

Jun 1, 2017
Sciwind Biosciences APAC CO Pty. Ltd.— Founded

Drugs by trial phase (11 distinct, 14 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT07243171Lead sponsorPhase 1/Phase 2Nov 18, 2025
NCT07143227Lead sponsorPhase 1Aug 25, 2025
NCT07073417Lead sponsorPhase 2Jul 28, 2025
NCT06335134Lead sponsorPhase 1Jul 14, 2023
NCT05779995Lead sponsorPhase 1/Phase 2Apr 20, 2023
NCT05813795Lead sponsorPhase 3Apr 5, 2023
NCT05680129Lead sponsorPhase 3Jan 10, 2023
NCT05680155Lead sponsorPhase 3Dec 29, 2022
NCT05579314Lead sponsorPhase 1Sep 26, 2022
NCT05184322CollaboratorPhase 1Feb 1, 2022
NCT05184322Lead sponsorPhase 1Feb 1, 2022
NCT05111912Lead sponsorPhase 2Nov 10, 2021
NCT05111912CollaboratorPhase 2Nov 10, 2021
NCT05083117CollaboratorPhase 2Oct 30, 2021
NCT05083117Lead sponsorPhase 2Oct 30, 2021

Details

Founded: Hangzhou, CN Jun 1, 2017
Last known activity: Nov 18, 2025